Back

Effect of testosterone therapy on cardiovascular risk factors, major adverse cardiovascular events and mortality in men with functional hypogonadism and cardiovascular disease in a real-world registry

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in the Elderly Cardiovascular Disease in the Elderly ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Farid Saad

Bayer AG, Berlin (Germany)

6 More presentations in this session

Presentation thumbnail
Frailty and multimorbidity as mortality risk indicators in older men
Professor T. Strandberg (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Differential effect of anticoagulation therapy in patients older versus younger than 80 years with atrial fibrillation and severe chronic kidney disease
Miss E. Fortuny Frau (Palma de Mallorca, ES)
Abstract Slides
Presentation thumbnail
An invasive strategy is associated with improved short- and long-term outcomes in acute myocardial infarction independently of frailty status and GRACE score: a nationwide analysis of 12144 episodes
Doctor G. Pessoa Amorim (Oxford, GB)
Abstract Slides
Presentation thumbnail
Increasing age as a major determinant of major adverse outcomes in patients with atrial fibrillation: the EURObservational research programme in atrial fibrillation general long-term registry
Professor G. Boriani (Modena, IT)
Abstract Slides
Presentation thumbnail
Long-term outcomes after transcatheter aortic valve implantation. An analysis of 5-year survival and beyond.
Doctor K. Stathogiannis (Stanford, US)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in the Elderly

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources